Sotorasib in KRASG12C mutated lung cancer

被引：0
|
作者：
Olivier, Timothee [1 ]
Prasad, Vinay [2 ]
机构：
[1] Geneva Univ Hosp, Dept Oncol, CH-1205 Geneva, Switzerland
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
来源：
LANCET | 2024年 / 403卷 / 10422期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Inhibition of ULK and KRASG12C control tumor growth in preclinical models of lung cancer
    Ghazi, Phaedra
    O'Toole, Kayla
    Boggaram, Sanjana
    Scherzer, Michael
    Bogdan, Madhumita
    Smith, Bryan
    Flynn, Dan
    Kinsey, Conan
    McMahon, Martin
    CANCER RESEARCH, 2024, 84 (06)
  • [42] Hedgehog signalling is involved in acquired resistance to KRASG12C inhibitors in lung cancer cells
    Lee, Chaeyoung
    Yi, Jawoon
    Park, Jihwan
    Ahn, Byungyong
    Won, Young-Wook
    Jeon, Jiheung
    Lee, Byung Ju
    Cho, Wha Ja
    Park, Jeong Woo
    CELL DEATH & DISEASE, 2024, 15 (01)
  • [43] Advances in the treatment of KRASG12C mutant non-small cell lung cancer
    Shaverdashvili, Khvaramze
    Burns, Timothy F.
    CANCER, 2025, 131
  • [44] Hedgehog signalling is involved in acquired resistance to KRASG12C inhibitors in lung cancer cells
    Chaeyoung Lee
    Jawoon Yi
    Jihwan Park
    Byungyong Ahn
    Young-Wook Won
    JiHeung Jeon
    Byung Ju Lee
    Wha Ja Cho
    Jeong Woo Park
    Cell Death & Disease, 15
  • [45] SOTORASIB IS ACTIVE IN KRASG12C-MUTANT NON-SMALL CELL LUNG CANCER
    Skoulidis, F.
    Li, B. T.
    Dy, G. K.
    Price, T. J.
    Falchook, G. S.
    Wolf, J.
    CANCER DISCOVERY, 2021, 11 (08) : 1870 - 1870
  • [46] PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib
    Chien-Hui Chan
    Li-Wen Chiou
    Tsai-Yu Lee
    Yun-Ru Liu
    Tsung-Han Hsieh
    Ching-Yao Yang
    Yung-Ming Jeng
    British Journal of Cancer, 2023, 128 : 148 - 159
  • [47] Progress on Covalent Inhibition of KRASG12C
    Westover, Kenneth D.
    Jaenne, Pasi A.
    Gray, Nathanael S.
    CANCER DISCOVERY, 2016, 6 (03) : 233 - 234
  • [48] KRASG12C inhibitor: combing for combination
    Chakraborty, Atanu
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (06) : 2691 - 2701
  • [49] The Effective Targeting of KRASG12C Elusiveness
    Elez, Filiation Elena
    Tabernero, Josep
    CANCER CELL, 2020, 38 (06) : 785 - 787
  • [50] Resistance looms for KRASG12C inhibitors
    Aaron N. Hata
    Alice T. Shaw
    Nature Medicine, 2020, 26 : 169 - 170
12345